3b Blackbio Dx Ltd vs Artemis Medicare Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 29, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1359 as of 29 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Artemis Medicare Services Ltd changed from 45.3 on March 2021 to 31.3 on March 2026 . This represents a CAGR of -5.98% over 6 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Artemis Medicare Services Ltd changed from ₹ 293.88 crore on March 2021 to ₹ 3249 crore on March 2026 . This represents a CAGR of 49.26% over 6 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Artemis Medicare Services Ltd for the Jun '26 is ₹ 292.7 crore as compare to the Mar '26 revenue of ₹ 287.01 crore. This represent the growth of 1.98% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Artemis Medicare Services Ltd for the Jun '26 is ₹ 61.82 crore as compare to the Mar '26 ebitda of ₹ 59.38 crore. This represent the growth of 4.11% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Artemis Medicare Services Ltd changed from ₹ 16.52 crore to ₹ 31.44 crore over 9 quarters. This represents a CAGR of 33.11% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Artemis Medicare Services Ltd changed from 15.2 % on March 2023 to 6.89 % on March 2026 . This represents a CAGR of -17.95% over 4 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Artemis Medicare Services Ltd

Artemis Medicare Services Limited was incorporated on May 18, 2004.
It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited.
At present, the Company is engaged in managing and operating of multi specialty hospitals.
Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multispeciality hospital located in Gurugram, India. Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group.

FAQs for the comparison of 3B Blackbio DX Ltd and Artemis Medicare Services Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Artemis Medicare Services Ltd?

Market cap of 3B Blackbio DX Ltd is 1,166 Cr while Market cap of Artemis Medicare Services Ltd is 4,720 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Artemis Medicare Services Ltd?

The stock performance of 3B Blackbio DX Ltd and Artemis Medicare Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Artemis Medicare Services Ltd?

As of October 29, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1359.45. On the other hand, Artemis Medicare Services Ltd stock price is INR ₹298.2.

How do dividend payouts of 3B Blackbio DX Ltd and Artemis Medicare Services Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Artemis Medicare Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.